The University College of London and Cellectis have signed a collaboration agreement to develop a T-cell adoptive immunotherapy to fight leukemia )-- Cellectis , the genome engineering specialist, announces today the signing of a broad collaboration agreement with the University College of London on the development of a therapy program to fight ... (more)
http://eon.businesswire.com/news/eon/20121218006227/en/Cellectis-Innovative-Anti-cancer-Approach
http://eon.businesswire.com/news/eon/20121218006227/en/Cellectis-Innovative-Anti-cancer-Approach
No comments:
Post a Comment